Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd that would impact on the consolidated financial statements and the separate financial statements.  Therefore, the SEC has notified EE (1) to review and

Earlier, the SEC notified NRF to cooperate with the auditor by providing information for reviewing its interim financial statements for the third quarter of 2024 and to rectify such interim financial

to Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd., which would impact EE’s consolidated financial statements and the separate financial statements. Therefore, the SEC notified EE to rectify the

The auditor expressed a qualified opinion on NRF’s interim financial statements for the third quarter of 2024 because the auditor was unable to obtain sufficient, appropriate audit evidence

Earlier, the SEC instructed CHARAN to cooperate with its auditor in reviewing the company’s interim financial statements for the first quarter of 2025, and to submit the rectified and reviewed

Earlier, the SEC notified JKN to rectify the financial statements for the year 2023 and submit the rectified financial statements that have been audited by the auditor to the SEC and simultaneously

Earlier, the SEC notified JKN to rectify the financial statements for the year 2023 that have been audited by the auditor to the SEC and simultaneously report the disclosure of related information

Purpose Acquisition Company or SPAC). As of the acquisition date, no merger with a target company has occurred, and the financial statements of KAL Group primarily consist of cash in trust under the SPAC

Earlier, the SEC notified NRF to rectify its financial statements for the year 2024 and Q1 of 2025 regarding the accounting of the change in the shareholding proportion in Kairous Asia Limited (KAL

) for colluding to make false entries and/or keep incomplete, incorrect or inaccurate accounts in JKN’s financial statements for the year 2023, and accounting documents for the first quarter of 2024 to